Legal & General Group
INMB icon

Legal & General Group’s INmune Bio INMB Stock Holding History

Legal & General Group’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.72K Sell
1,520
-296
-16% -$422 ﹤0.01% 3346
2025
Q4 		$2.83K Hold
1,816
– – ﹤0.01% 3364
2025
Q3 		$3.76K Hold
1,816
– – ﹤0.01% 3383
2025
Q2 		$4.2K Buy
1,816
+458
+34% +$3.36K ﹤0.01% 3394
2025
Q1 		$10.6K Hold
1,358
– – ﹤0.01% 3158
2024
Q4 		$6.34K Hold
1,358
– – ﹤0.01% 3318
2024
Q3 		$7.32K Hold
1,358
– – ﹤0.01% 3325
2024
Q2 		$12K Buy
+1,358
New +$13.4K ﹤0.01% 3246

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Legal & General Group's INMB Position: Q1 2026 in Review

Legal & General Group reduced its INmune Bio (INMB) stake by 16% in Q1 2026, selling an estimated $422 and leaving 1,520 shares worth $1.72K. The position accounts for ﹤0.01% of the portfolio, ranked #3346.

Legal & General Group first reported a position in INMB in Q2 2024 and has held it in 8 quarters since. The position peaked at $12K in Q2 2024. 82 funds tracked by Wall St. Rank hold INMB as of Q1 2026.

  • Legal & General Group held 1,520 shares of INmune Bio worth $1.72K as of Q1 2026.
  • Legal & General Group sold 296 INmune Bio shares in Q1 2026, an estimated $422.
  • INmune Bio made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #3346 holding.
  • Legal & General Group first reported a position in INmune Bio in Q2 2024 and has held it in 8 quarters since.
  • Legal & General Group's INmune Bio position peaked at $12K in Q2 2024.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.